168 related articles for article (PubMed ID: 34216408)
1. A pH-Triggered Self-Unpacking Capsule Containing Zwitterionic Hydrogel-Coated MOF Nanoparticles for Efficient Oral Exendin-4 Delivery.
Zhou Y; Chen Z; Zhao D; Li D; He C; Chen X
Adv Mater; 2021 Aug; 33(32):e2102044. PubMed ID: 34216408
[TBL] [Abstract][Full Text] [Related]
2. A Nanocomposite Vehicle Based on Metal-Organic Framework Nanoparticle Incorporated Biodegradable Microspheres for Enhanced Oral Insulin Delivery.
Zhou Y; Liu L; Cao Y; Yu S; He C; Chen X
ACS Appl Mater Interfaces; 2020 May; 12(20):22581-22592. PubMed ID: 32340452
[TBL] [Abstract][Full Text] [Related]
3. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
[TBL] [Abstract][Full Text] [Related]
4. Sustained Release of Exendin 4 Using Injectable and Ionic-Nano-Complex Forming Polymer Hydrogel System for Long-Term Treatment of Type 2 Diabetes Mellitus.
Seo BB; Park MR; Song SC
ACS Appl Mater Interfaces; 2019 May; 11(17):15201-15211. PubMed ID: 30945843
[TBL] [Abstract][Full Text] [Related]
5. Oral delivery of exenatide-loaded hybrid zein nanoparticles for stable blood glucose control and β-cell repair of type 2 diabetes mice.
Bao X; Qian K; Yao P
J Nanobiotechnology; 2020 Apr; 18(1):67. PubMed ID: 32345323
[TBL] [Abstract][Full Text] [Related]
6. Charge-switchable zwitterionic polycarboxybetaine particle as an intestinal permeation enhancer for efficient oral insulin delivery.
Li Y; Ji W; Peng H; Zhao R; Zhang T; Lu Z; Yang J; Liu R; Zhang X
Theranostics; 2021; 11(9):4452-4466. PubMed ID: 33754071
[TBL] [Abstract][Full Text] [Related]
7. Evaluating UiO-66 Metal-Organic Framework Nanoparticles as Acid-Sensitive Carriers for Pulmonary Drug Delivery Applications.
Jarai BM; Stillman Z; Attia L; Decker GE; Bloch ED; Fromen CA
ACS Appl Mater Interfaces; 2020 Sep; 12(35):38989-39004. PubMed ID: 32805901
[TBL] [Abstract][Full Text] [Related]
8. The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo.
Nguyen HN; Wey SP; Juang JH; Sonaje K; Ho YC; Chuang EY; Hsu CW; Yen TC; Lin KJ; Sung HW
Biomaterials; 2011 Apr; 32(10):2673-82. PubMed ID: 21256586
[TBL] [Abstract][Full Text] [Related]
9. Sustained release of exendin-4 from tannic acid/Fe (III) nanoparticles prolongs blood glycemic control in a mouse model of type II diabetes.
He Z; Hu Y; Gui Z; Zhou Y; Nie T; Zhu J; Liu Z; Chen K; Liu L; Leong KW; Cao P; Chen Y; Mao HQ
J Control Release; 2019 May; 301():119-128. PubMed ID: 30894322
[TBL] [Abstract][Full Text] [Related]
10. Exendin-4 Loaded Nanoparticles with a Lipid Shell and Aqueous Core Containing Micelles for Enhanced Intestinal Absorption.
Chen C; Zhu X; Dou Y; Xu J; Zhang J; Fan T; Du J; Liu K; Deng Y; Zhao L; Huang Y
J Biomed Nanotechnol; 2015 May; 11(5):865-76. PubMed ID: 26349398
[TBL] [Abstract][Full Text] [Related]
11. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
[TBL] [Abstract][Full Text] [Related]
12. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.
Fan W; Xia D; Zhu Q; Li X; He S; Zhu C; Guo S; Hovgaard L; Yang M; Gan Y
Biomaterials; 2018 Jan; 151():13-23. PubMed ID: 29055774
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamical effects of orally administered exenatide nanoparticles embedded in gastro-resistant microparticles.
Soudry-Kochavi L; Naraykin N; Di Paola R; Gugliandolo E; Peritore A; Cuzzocrea S; Ziv E; Nassar T; Benita S
Eur J Pharm Biopharm; 2018 Dec; 133():214-223. PubMed ID: 30342089
[TBL] [Abstract][Full Text] [Related]
14. zwitterionic Pluronic analog-coated PLGA nanoparticles for oral insulin delivery.
Liu K; Chen Y; Yang Z; Jin J
Int J Biol Macromol; 2023 May; 236():123870. PubMed ID: 36870645
[TBL] [Abstract][Full Text] [Related]
15. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
[TBL] [Abstract][Full Text] [Related]
16. Alginate/chitosan nanoparticles are effective for oral insulin delivery.
Sarmento B; Ribeiro A; Veiga F; Sampaio P; Neufeld R; Ferreira D
Pharm Res; 2007 Dec; 24(12):2198-206. PubMed ID: 17577641
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of oral insulin bioavailability: in vitro and in vivo assessment of nanoporous stimuli-responsive hydrogel microparticles.
Ahmad N; Mohd Amin MC; Ismail I; Buang F
Expert Opin Drug Deliv; 2016; 13(5):621-32. PubMed ID: 26943455
[TBL] [Abstract][Full Text] [Related]
18. A composite hydrogel system containing glucose-responsive nanocarriers for oral delivery of insulin.
Li L; Jiang G; Yu W; Liu D; Chen H; Liu Y; Huang Q; Tong Z; Yao J; Kong X
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():37-45. PubMed ID: 27612686
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the hypoglycemic effect of exendin-4's new oral self-nanoemulsifying system in rats.
Celik-Tekeli M; Celebi N; Tekeli MY; Aktas Y
Eur J Pharm Sci; 2021 Mar; 158():105644. PubMed ID: 33197556
[TBL] [Abstract][Full Text] [Related]
20. Metal-organic framework-based hydrogel with structurally dynamic properties as a stimuli-responsive localized drug delivery system for cancer therapy.
Zeng Y; Zhang C; Du D; Li Y; Sun L; Han Y; He X; Dai J; Shi L
Acta Biomater; 2022 Jun; 145():43-51. PubMed ID: 35398545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
